Hollencrest Capital Management Seelos Therapeutics, Inc. Transaction History

Hollencrest Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$0.66 - $259.46 $1,716 - $674,596	2,600 New	2,600 $1,000
Q4 2021 Jan 07, 2022	SELL	$1.59 - $2.38 $35,934 - $53,788	-22,600 Closed	0 $0
Q3 2021 Oct 13, 2021	SELL	$1.69 - $2.89 $1,690 - $2,890	-1,000 Reduced 4.24%	22,600 $54,000
Q2 2021 Jul 21, 2021	BUY	$2.64 - $6.32 $1,584 - $3,792	600 Added 2.61%	23,600 $63,000
Q1 2021 Apr 29, 2021	BUY	$1.35 - $4.99 $31,050 - $114,770	23,000 New	23,000 $115,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $117M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

Stay updated on Hollencrest Capital Management with notifications on news.